| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Smith Sherrell | EVP, Chief Academic Officer | 4225 E. WINDROSE DRIVE, SUITE 200, PHOENIX | /s/ Christopher Kevane, Attorney-in-Fact for Sherrell Smith | 04 Mar 2026 | 0001371105 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | UTI | Common Stock, $0.0001 par value | Sale | $1,109,823 | -30,000 | -19% | $36.99 | 129,375 | 02 Mar 2026 | Direct | F1 |
| transaction | UTI | Common Stock, $0.0001 par value | Award | +25,920 | +63% | $0.000000* | 67,139 | 08 Dec 2025 | Spouse | F2 | |
| transaction | UTI | Common Stock, $0.0001 par value | Award | +3,718 | +5.5% | 70,857 | 10 Dec 2025 | Spouse | F3, F4 | ||
| transaction | UTI | Common Stock, $0.0001 par value | Tax liability | -7,219 | -10% | $24.55* | 63,638 | 11 Dec 2025 | Spouse | F5 | |
| transaction | UTI | Common Stock, $0.0001 par value | Tax liability | -1,776 | -2.8% | $24.55* | 61,862 | 11 Dec 2025 | Spouse | F6 | |
| transaction | UTI | Common Stock, $0.0001 par value | Tax liability | -881 | -1.4% | $24.55* | 60,981 | 11 Dec 2025 | Spouse | F7 | |
| transaction | UTI | Common Stock, $0.0001 par value | Tax liability | -836 | -1.4% | $26.06* | 60,145 | 17 Dec 2025 | Spouse | F8 | |
| transaction | UTI | Common Stock, $0.0001 par value | Sale | $841,198 | -22,671 | -38% | $37.10 | 37,474 | 02 Mar 2026 | Spouse | F9 |
| Id | Content |
|---|---|
| F1 | The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $36.75 to $37.21. The reporting person undertakes to provide the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein. |
| F2 | Shares underlying a performance-based restricted stock unit award that was earned on the basis of the Issuer's achievement of certain performance vesting criteria (as stated in the agreement governing the award). |
| F3 | The restricted stock units vest in three equal installments beginning on December 15, 2026. |
| F4 | Each restricted stock unit represents a contingent right to receive one share of Issuer's Common Stock. |
| F5 | Shares withheld by the Issuer to satisfy tax-withholding obligations upon settlement of the performance-based restricted stock units granted on December 8, 2022. |
| F6 | Shares withheld by the Issuer to satisfy tax-withholding obligations upon vesting of restricted stock units granted on December 8, 2022. |
| F7 | Shares withheld by the Issuer to satisfy tax-withholding obligations upon vesting of restricted stock units granted on December 8, 2023. |
| F8 | Shares withheld by the issuer to satisfy tax-withholding obligations upon vesting of restricted stock units granted on December 9, 2024. |
| F9 | The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $36.88 to $37.35. The reporting person undertakes to provide the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein. |